PR Newswire02.28.18
Heraeus Medical, a company specializing in joint fixation and infection management announced the introduction of innovations to its current PALACOS product portfolio. The new products include the medium viscosity bone cement PALACOS MV variations, along with two mixing systems, PALAMIX and PALABOWL.
PALAMIX and PALABOWL, while created for use with PALACOS bone cement, can be effectively used with other types of bone cements. These new products, along with the complete PALACOS portfolio, will be displayed during the American Academy of Orthopedic Surgeons' Annual Meeting, March 6-10, 2018 in New Orleans. AAOS attendees wanting to learn more about the medium viscosity bone cement, versatile mixing options or view other ground-breaking products are encouraged to visit Heraeus Medical at booth 1713 and participate in demonstrations and discussions.
"The collaborative environment of AAOS provides an excellent opportunity to share our newest technologies with total joint arthroplasty surgeons and gain direct feedback," said Devin Childers, Vice President and General Manager of Heraeus Medical LLC. "Heraeus is excited to share our rapidly growing portfolio with attendees."
In January, the company announced it would provide PALACOS customers with earlier access to its latest technologies by selling to them directly. PALACOS, formerly sold exclusively through a distributor in the US, is now available directly through its pioneer and manufacturer, Heraeus Medical.
PALAMIX and PALABOWL, while created for use with PALACOS bone cement, can be effectively used with other types of bone cements. These new products, along with the complete PALACOS portfolio, will be displayed during the American Academy of Orthopedic Surgeons' Annual Meeting, March 6-10, 2018 in New Orleans. AAOS attendees wanting to learn more about the medium viscosity bone cement, versatile mixing options or view other ground-breaking products are encouraged to visit Heraeus Medical at booth 1713 and participate in demonstrations and discussions.
"The collaborative environment of AAOS provides an excellent opportunity to share our newest technologies with total joint arthroplasty surgeons and gain direct feedback," said Devin Childers, Vice President and General Manager of Heraeus Medical LLC. "Heraeus is excited to share our rapidly growing portfolio with attendees."
In January, the company announced it would provide PALACOS customers with earlier access to its latest technologies by selling to them directly. PALACOS, formerly sold exclusively through a distributor in the US, is now available directly through its pioneer and manufacturer, Heraeus Medical.